Advanced statistical methods to study the effects of gastric tube and non-invasive ventilation on functional decline and survival in amyotrophic lateral sclerosis

References

• Chicago Uo. Ceftriaxone as effective therapy in refractory Lyme disease. The Journal of Infectious Diseases. 1987;155: 1322–4.
   PubMed Web of Science ®Google Scholar
• Brooks BR. Natural history of ALS. Neurology. 1996;47 (Suppl 2):S71–82.
   Google Scholar
• Del Piano M, Occhipinti P, Orsello M, Balare M. Percutaneous endoscopic gastrostomy (PEG) reduces complications and improves survival in amyotrophic lateral sclerosis (ALS). Gastrointest Endosc. 1999;49:192.
   PubMed Web of Science ®Google Scholar
• Mazzini L, Corrá T, Zaccala M, Mora G, Del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1995;242:695–8.
   Google Scholar
• Desport JC, Preux PM, Truong CT, Courat L, Vallat JM, Couratier P. Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;2:91–6.
   Google Scholar
• Mitsumoto H, Davidson M, Moore D, Gad N, Brandis M, Ringel S, . Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:177–85.
   PubMed Web of Science ®Google Scholar
• Mathus-Vliegen LMH, Louwerse LS, Merkus MP, Tytgat GNJ, Vianney de Jong JMB. Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function. Gastrointestinal Endoscopy. 1994;40:463–9.
   PubMed Web of Science ®Google Scholar
• Shaw A, Ampong M-A, Rio A, Al-Chalabi A, Sellars M, Ellis C, . Survival of patients with ALS following institution of enteral feeding is related to pre-procedure oximetry: A retrospective review of 98 patients in a single centre. Amyotroph Lateral Scler. 2006;7:16–21.
   PubMed Web of Science ®Google Scholar
• Forbes RB, Colville S, Swingler RJ. Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neuron disease. J Neurol. 2004;251:813–7.
   PubMed Web of Science ®Google Scholar
• Bourke SC, Bullock RE, Williams TL, Shaw PJ, Gibson GJ. Non-invasive ventilation in ALS. Neurology. 2003;61:171–7.
   PubMed Web of Science ®Google Scholar
• Sherman M, Paz H. Review of respiratory care of the patient with amyotrophic lateral sclerosis. Respiration. 1994;61: 61–7.
   PubMed Web of Science ®Google Scholar
• Aboussounan L, Khan S, Meeker D, Stelmach K, Mitsumoto H. Effect of non-invasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Int Med. 1997;127:450–3.
   PubMed Web of Science ®Google Scholar
• Kleopa K, Sherman M, Neal B, Romano G, Heiman-Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci. 1999;164:82–8.
   PubMed Web of Science ®Google Scholar
• Pinto A, Evangelista T, Carvalho M, Alves M, Saslue L. Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial. J Neurol Sci. 1995;129:19–26.
   PubMed Web of Science ®Google Scholar
• Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550–60.
   PubMed Web of Science ®Google Scholar
• Hernán MA, Brumback BA, Robins JM. Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. Statistics in Medicine. 2002;21:1689–709.
   PubMed Web of Science ®Google Scholar
• Cudkowicz M, Shefner J, Schoenfeld D, Zhang H, Andreasson K, Rothstein J, . Trial of celecoxib in amyotrophic lateral sclerosis. Annals of Neurology. 2006;60:22–31.
   PubMed Web of Science ®Google Scholar
• Ferrante KL, Shefner J, Zhang H, Betensky R, O'Brien M, Yu H, . Tolerance of high-dose (3000 mg/day) coenzyme Q10 in ALS. Neurology. 2005;65:1834–6.
   PubMed Web of Science ®Google Scholar
• Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’. J Neurol Sci. 1994;124:96–107.
   PubMed Web of Science ®Google Scholar
• Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, . Practice Parameter update. The care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review). Neurology. 2009;73:1218–26.
   PubMed Web of Science ®Google Scholar
• Katzberg H, Benatar M. Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2011;19(1):CD004030.
   Google Scholar
• Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, . Practice parameter. The care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 1999;52:1311.
   PubMed Web of Science ®Google Scholar
• Lavori PW, Dawson R. Dynamic treatment regimes: practical design considerations. Clinical Trials. 2004;1:9–20.
   PubMedGoogle Scholar